Strattera and Glucotrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Glucotrol (glipizide). Common drug interactions include blood cholesterol increased among females and hyperhidrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Glucotrol. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Glucotrol?

Glucotrol has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 20,322 Glucotrol users. Check the latest studies of Glucotrol.



On Aug, 05, 2026

12 people who take Strattera and Glucotrol together, and have interactions are studied.

Strattera and Glucotrol drug interactions.

What are the common drug interactions of Strattera and Glucotrol, by gender? *:

female:

  1. Blood cholesterol increased
  2. Cystitis (inflammation of the wall of the bladder)
  3. Dyspnoea (difficult or laboured respiration)
  4. Heart rate increased
  5. Insulin resistance
  6. Morton's neuroma (a nerve tumour non cancer that affects one of the nerves that run between the long bones (metatarsals) in the foot)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Pyuria (a condition of urine containing pus)
  9. Anxiety
  10. Blood glucose increased

male:

  1. Hyperhidrosis (abnormally increased sweating)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Diarrhoea
  4. Dizziness
  5. Dry mouth
  6. Dysarthria (speech disorder)
  7. Dysuria (painful or difficult urination)
  8. Fatigue (feeling of tiredness)
  9. Glycosylated haemoglobin decreased
  10. Heart rate increased

What are the common drug interactions of Strattera and Glucotrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chest pain
  2. Dysuria (painful or difficult urination)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
  6. Nightmare (unpleasant dream)
  7. Panic reaction
  8. Restless legs syndrome (a powerful urge to move your legs)
  9. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  10. Urinary tract infection

40-49:

  1. Blood glucose decreased
  2. Drug ineffective
  3. Dysarthria (speech disorder)
  4. Glycosylated haemoglobin decreased
  5. Hyperglycaemia (high blood sugar)
  6. Hyperhidrosis (abnormally increased sweating)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Weight increased

50-59:

  1. Hyperhidrosis (abnormally increased sweating)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Fatigue (feeling of tiredness)
  4. Heart rate increased
  5. Hot flush (sudden feelings of heat)
  6. Hypersomnia (excessive daytime sleepiness (eds))
  7. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  8. Vomiting
  9. Flushing (the warm, red condition of human skin)
  10. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)

60+:

n/a

What are the existing conditions these people have? *

  1. Inner Ear Disorder: 2 people, 16.67%
  2. High Blood Cholesterol: 2 people, 16.67%
  3. Type 2 Diabetes: 1 person, 8.33%
  4. Insomnia (sleeplessness): 1 person, 8.33%
  5. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 8.33%
  6. Depression: 1 person, 8.33%
  7. Bipolar Disorder (mood disorder): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Glucotrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Strattera and Glucotrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucotrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Strattera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucotrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride and glipizide (the active ingredients of Strattera and Glucotrol, respectively), and Strattera and Glucotrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: